SOPHiA GENETICS SA

Listed Company
SOPHCIK 0001840706NasdaqAcceleratedEmerging GrowthServices-Computer Processing & Data PreparationV8CHFY ends Dec 31
Period
FY 2025
Revenue
Net Income
$-79.00M
Total Assets
$163.03M
Equity
Shares Out
68.49M
Op. Cash Flow

Business

SOPHiA GENETICS SA is a cloud-native software technology company that provides decentralized analytics to enable data-driven medicine by standardizing and analyzing complex multimodal healthcare data. It offers the SOPHiA DDM Platform and modules including genomic and radiomic applications, SOPHiA CarePath, the Alamut interpretation suite, and branded biopharma applications such as SOPHiA Insights, Trial Match, CDx and Awareness, plus related services and access models. The company serves clinical and biopharma segments, targeting hospitals, reference and specialty laboratories and pharmaceutical/biotech customers. Its solutions are distributed globally through a direct sales force, local distributors and collaborator networks and are deployed across regional cloud data centers in multiple countries.

Summary from filing dated 2025-03-04

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income$-79.00M
Total assets$163.03M
Total liabilities$115.89M
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro